文献速递主动脉疾病颈动脉与弓上血管

颈动脉-颈动脉转位用于0区胸主动脉腔内修复

Carotid-Carotid Transposition for Zone 1 Thoracic Endovascular Aortic Repair.
PubMed 文献 · Ann Vasc Surg · 2021-05-02

单中心回顾性分析13例0区TEVAR前接受颈动脉-颈动脉转位(CCT)的患者,干预指征为高血压相关的胸/胸腹主动脉瘤或夹层、Marfan综合征及Turner综合征。CCT相关并发症仅1例暂时性单侧喉返神经损伤,无脑血管事件、手术部位感染或手术相关死亡;随访影像显示转位血管均通畅。作者认为CCT是0区TEVAR时左颈总动脉血运重建的安全自体替代方案。

要点

  • CCT可作为颈动脉-颈动脉旁路的自体替代方案,用于0区TEVAR时左颈总动脉血运重建。
  • 本组CCT相关并发症为1例暂时性单侧喉返神经损伤,无脑血管事件及手术相关死亡。
  • 随访影像显示转位血管均通畅,无狭窄或血栓形成。

核心结论

  • CCT是0区TEVAR时左颈总动脉血运重建的安全自体替代方案,可替代颈动脉-颈动脉旁路。

研究设计与样本

  • 单中心回顾性研究,纳入2017至2020年按CPT编码35509识别的接受CCT的全部患者,共13例在0区TEVAR前接受CCT。

主要发现

  • 干预指征为继发于高血压的胸或胸腹主动脉瘤及夹层(n=10)、Marfan综合征(n=2)、Turner综合征既往主动脉缩窄修复后动脉瘤样退变(n=1)。
  • 队列中既存高血压占92%、营养不良占69%、吸烟占61%。
  • 手术为择期7例(54%)、紧急6例(46%)。
  • CCT直接相关并发症为暂时性单侧喉返神经损伤1例(7.7%),无脑血管事件、手术部位感染或手术相关死亡。
  • 有随访影像的转位血管均通畅、无狭窄或血栓形成(平均7.2个月,n=10),无CCT相关远期并发症。

临床怎么用

  • 在0区TEVAR需维持左颈总动脉灌注时,可将CCT作为颈动脉-颈动脉旁路的自体替代术式考虑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Carotid-carotid bypass is the standard technique for cervical aortic arch debranching to maintain left common carotid artery perfusion with zone I thoracic endovascular aortic repair (TEVAR), while left-to-right carotid-carotid transposition (CCT) has been described as an autologous alternative. We report on our center's experience with CCT in the setting of zone I TEVAR. This is the only published series of this technique. METHODS: All patients who underwent CCT, defined by CPT code 35509, between 2017 and 2020 were identified at our tertiary care center. Patient demographics, indications for CCT, complications specific to CCT, operative details, post-operative course, and outcomes were retrospectively reviewed. RESULTS: A total of 13 patients underwent CCT prior to zone 1 TEVAR. The indications for intervention were thoracic or thoracoabdominal aortic aneurysms and dissections secondary to hypertension (n = 10), Marfan syndrome (n = 2), and Turner syndrome with aneurysmal degeneration of previous coarctation repair (n = 1). There was a high incidence of preexisting hypertension (92%), malnutrition (69%), and smoking (61%) in this cohort. Operative intervention was performed on both an elective (n = 7, 54%) and an urgent (n = 6, 46%) basis. Complications directly related to CCT included transient unilateral recurrent laryngeal nerve deficit (n = 1, 7.7%). There were no cerebrovascular events, surgical site infections, or procedure-related mortalities. All transpositions with follow-up imaging were patent without stenosis or thrombosis (average 7.2 months, n = 10). There were no late complications related to CCT. CONCLUSIONS: CCT is a safe and autologous alternative to carotid-carotid bypass for left common carotid artery revascularization with zone I TEVAR.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Aru RG, Tyagi SC, Minion DJ, et al. Carotid-Carotid Transposition for Zone 1 Thoracic Endovascular Aortic Repair. Ann Vasc Surg. 2021. PMID: 33951527. doi:10.1016/j.avsg.2021.04.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。